Searchable abstracts of presentations at key conferences in endocrinology

ea0014p120 | (1) | ECE2007

Ret expression reduces estrogen-induced lactotrope hyperplasia

Cañibano Carmen , Rodríguez Noela , Tovar Sulay , Vázquez María Jesús , Lavandeira Montserrat , Díeguez Carlos , Álvarez Clara

RET is a tyrosine kinase receptor activated by GDNF, NTN, ART and PSPN through GFRa1,2, 3 and 4 respectively. Activation of the receptor elicits intracellular pathways such us Ras/MAPK and PI3K/AKT leading to differentiation and proliferation. Our group has previously shown that RET is expressed specifically in the somatotroph cell population within the pituitary gland, both in rats and in humans. We have also shown that, in absence of its ligand GDNF, RET induces activation o...

ea0056gp25 | Adrenal clinical | ECE2018

Metabolic fingerprints after Cushing syndrome cure

Garcia-Eguren Guillermo , Vizan Pedro , Gonzalez Mar , Blanco Enrique , Rojo Marina , Mora Mireia , Giro Oriol , Halperin Irene , Di Croce Luciano , Hanzu Felicia A

Introduction: Active hypercortisolism of Cushing syndrome (CS) determines major changes in the plasticity and function of metabolic key target tissues as the adipose tissue (AT). Persistence of target tissue altered metabolic memory after the cure/remission of Cushing syndrome is still at debate as clinical observational studies are limited due to confounder factors both in endogenous as exogenous CS. We postulate that after remission of hypercortisolism, adipose tissue (AT) p...

ea0056p639 | Diabetes (to include epidemiology, pathophysiology) | ECE2018

Optimization of the use of outpatient diabetes center through a coordinated task force between primary care and endocrinology unit

Belen Ojeda Schuldt Maria , Mateo Gavira Isabel , Sanchez Lechuga Begona , Larran Escandon Laura , Roca Rodriguez Mar , Zarallo Perez Antonio , Aguilar Diosdado Manuel

Objetives: To analyze the profile of patients referred from Primary Care (PC) to Outpatient Diabetes Center (ODC), as well as the evolution of self-assessment measured by Chronic Care Model IEMAC (Instrument for the Evaluation of Attention Chronicity Models) tool after implementation of a coordinated Task Force between Primary Care and Endocrinology Unit.Methods: The working group of the Advanced Diabetes Center in Cádiz-San Fernando Sanitary Area w...

ea0073pep15.5 | Presented ePosters 15: Late Breaking | ECE2021

Pheochromocytoma secreting IL-6; an atypical presentation

Laura García María , Lisdero Ana Paula , González Pernas Mariana , Speroni Romina , Segarra Ana , Otero Jimena , Genovesi Elbio , Belli Susana , Giselle Mumbach Aizhar

Pheochromocytoma (PCC) is a rare tumor that arises from the adrenal medulla, usually presents with headache, sweating and palpitations due to excessive catecholamine release. However, PCC may secrete neuropeptides, hormones and cytokines, such as interleukin-6 (IL-6)) resulting in unusual clinical manifestations. A 48-year-old woman with a previous history of type 1 neurofibromatosis (NF1) and hypertension was referred to discarded PCC. Laboratory tests revealed leukocytosis a...

ea0073aep252 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Inhibition of ATG3 ameliorates liver steatosis by increasing SIRT1 in an autophagic-independent action

Novoa Eva , Nátalia da Silva Lima , Marcos Férnandez Fondevila , Buque Xabier , María Jesús González Rellán , Uxía Fernández Paz , María García Vence , María del Pilar Chantada Vázquez , Bravo Susana , Patricia Marañon , Escudero Adriana , Leiva Magdalena , Fidalgo Miguel , Gomes Pedro , Claret Marc , Sabio Guadalupe , Rey Marta Varela , Delgado Teresa , Miguel López , Carlos Diéguez , María Martínez Chantar , Carmelo García Monzon , Agueda González Rodríguez , Aspichueta Patricia , Rubén Nogueiras Pozo

Background and aimsNonalcoholic fatty liver disease (NAFLD) is a major health threat in both developed and developing countries and is a precursor of the more advanced liver diseases including nonalcoholic steatohepatitis (NASH), liver cirrhosis and liver cancer. One of the numerous molecules participating in the development of liver steatosis is p63. Although p63 is mainly known for its roles as a tumor suppressor and cell maintenance and renewal, we ha...

ea0073aep349 | Diabetes, Obesity, Metabolism and Nutrition | ECE2021

Implementation of flash glucose monitoring system in a regional hospital in the province of Cordoba

Ana Barrera Martín , Mª del Carmen Serrano Laguna , Rocío Domínguez Rabadán , María Ángeles Gálvez Moreno

IntroductionThe development of flash glucose monitoring system (FGM) has led to a change in the paradigm of diabetes control, beyond the evaluation of glycosylated hemoglobin (HbA1c). FGM allows to improve control of type 1 diabetes mellitus (T1DM) and the quality of life of patients.ObjectiveDescribe the baseline characteristics of patients with T1DM in a regional hospital in the southern area of the provinc...

ea0073aep621 | Reproductive and Developmental Endocrinology | ECE2021

Experience of the transgender care unit

Moreno-Moreno Paloma , Ángel Rebollo-Román , Mª Rosa Alhambra Expósito , MaríaÁngeles Gálvez-Moreno

ObjectiveHealth care for transsexuals has changed in Andalucia since 2014. Our unit of attention to transsexual people began in 2015. The objective of this study is to analyze our experience.Patients and methodsRetrospective study by reviewing the medical records of the transsexuals treated in our unit.Results145 transsexual people. Transsexual man to woman (TMW):...

ea0073ep207 | Thyroid | ECE2021

Patients with differentiated thyroid cancer treated with low iodine dose: clinical results

Redondo Enrique , Sara León Utrero , María Del Carmen Andreo-Lopez , Mª del Carmen Serrano Laguna , Hayon Ponce Maria , Maria Dolores Aviles Perez

Introduction and objectivesThyroid cancer treatment tends to be individualized based on risk stratification and increasingly less aggressive for low-risk tumors, as recent studies have shown that low doses of I-131 are just as effective than higher doses with excellent remission rates. The objective of our study was to evaluate the response after 1 year of treatment with 30 mCi of I-131 in patients with differentiated thyroid cancer.<p class="abstext...

ea0070aep284 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Inflammasome components and food addiction behaviors in morbid obesity and bariatric surgery: Novel promising targets for a chronic disease

Herrero-Aguayo Vicente , Sáez-Martínez Prudencio , Luis López-Cánovas Juan , Jesús Montero-Hidalgo Antonio , Membrives Antonio , David Gahete Manuel , José Molina-Puerta María , Pastor Castaño Justo , Ángeles Gálvez-Moreno María , Miguel Luque Raúl , Dulcinea Herrera-Martínez Aura

Obesity is a chronic metabolic disease associated with important metabolic and inflammatory comorbidities, which can be reversed or improved after bariatric-surgery (BS). However, some underlying mechanisms, independent of weight-loss, are still unknown. In this context, dysregulations in the inflammasome, a multiproteic complex that promotes cytokine maturation and induces cellular pyroptosis, has been associated to the development/stage of some cancer-types and obesity. Howe...

ea0070aep331 | Diabetes, Obesity, Metabolism and Nutrition | ECE2020

Clinical and metabolic benefits of sodium-glucose cotransporter 2 inhibitors (SGLT2i) therapy in diabetic patients with psychiatric comorbidities

Concepción Terroba-Larumbe María , Crespo-Soto Cristina , Palacio-Mures Jose Maria , Gonzalez-Sagrado Manuel , Conde-Vicente Rosa , Ventosa-Viña Marta , Peña-Lozano Silvia , Portela-Martin Ainara , Fernandez-Nuñez Marta , Calleja-Barnada Mar , Cuellar-Olmedo Luis

Introduction: Sodium-glucose cotransporter 2 inhibitors (SGLT2i) therapyhas proven effective in type 2 diabetes but there is little data on its effect in patients with psychiatric comorbidity, who usually present worse metabolic and clinical control. The aim of this study was to evaluate if there are differences in the effect of this therapy in relation to the presence of these pathologies.Methods: 225 patients included in a therapy protocol with SGLT2i,...